Skip to main content

TD Asset Management Inc

SEC CIK
0001056053
Latest filing
Aug 4, 2026

WST holding history

West Pharmaceutical Services Inc in every 13F filed by TD Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

WST overviewAll 13F holders of WSTFull Q2 2026 holdings

Shares (Q2 2026)
731,054
Value
$262.4M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of WST by TD Asset Management Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026731,054$262.4M0.2%−37,899−4.9%ReducedHolders
Q1 2026768,953$192.7M0.2%+163,227+26.9%AddedHolders
Q4 2025605,726$166.7M0.1%−606−0.1%ReducedHolders
Q3 2025606,332$159.1M0.1%+125,398+26.1%AddedHolders
Q2 2025480,934$105.2M0.1%+42,549+9.7%AddedHolders
Q1 2025438,385$98.1M0.1%+25,372+6.1%AddedHolders
Q4 2024413,013$135.3M0.1%−37,294−8.3%ReducedHolders
Q3 2024450,307$140.0M0.1%−80,728−15.2%ReducedHolders
Q2 2024531,035$174.9M0.2%−88,669−14.3%ReducedHolders
Q1 2024619,704$245.2M0.2%−39,856−6.0%ReducedHolders
Q4 2023659,560$232.2M0.2%+183,153+38.4%AddedHolders
Q3 2023476,407$178.8M0.2%+37,153+8.5%AddedHolders
Q2 2023439,254$168.0M0.2%−4,756−1.1%ReducedHolders
Q1 2023444,010$153.8M0.2%+123,224+38.4%AddedHolders
Q4 2022320,786$75.5M0.1%+52,330+19.5%AddedHolders
Q3 2022268,456$67.5M0.1%−4,072−1.5%ReducedHolders
Q2 2022272,528$82.4M0.1%−18,922−6.5%ReducedHolders
Q1 2022291,450$119.7M0.1%−1,777−0.6%ReducedHolders
Q4 2021293,227$137.5M0.1%+91,923+45.7%AddedHolders
Q3 2021201,304$85.5M0.1%+16,538+9.0%AddedHolders
Q2 2021184,766$76.1M0.1%+22,462+13.8%AddedHolders
Q1 2021162,304$45.7M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.